Best Practices in Prostacyclin Therapy for Pulmonary Arterial Hypertension in the Hospitalized Patient

Ronald J. Oudiz, MD, is a Professor of Medicine and the Director of the Pulmonary Hypertension Center at the David Geffen School of Medicine at UCLA, and is a Faculty Cardiologist at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center in Southern California. He received his Medical School training at the University of Southern California in Los Angeles, his Internal Medicine training at the University of California, San Diego, and his training in Cardiovascular Diseases at Harbor-UCLA Medical Center in Torrance, CA, USA. Dr Oudiz is board-certified in Internal Medicine and Cardiovascular Diseases. He is a past holder of scientific research awards from the American Heart Association and the National Institutes of Health, received the Pulmonary Hypertension Association (PHA) Award of Excellence in Pulmonary Arterial Hypertension (PAH) Care in 2011, and was a 2015 PHA Legacy Award Recipient. He is the Chair-Elect of the PHA Scientific Leadership Council. Dr. Oudiz has authored several papers in pulmonary hypertension and has presented his research at national and international seminars. He is a past Editor-in- Chief of the scientific publication Advances in Pulmonary Hypertension, and immediate past chair of the Pulmonary Vascular NetWork, American College of Chest Physicians. Dr. Oudiz has participated in several trials of innovative medical treatments for pulmonary hypertension, many of which are still ongoing. His research focus has been to describe the physiologic abnormalities that are caused by PH using measurements of lung gas exchange during exercise, and to study exercise rehabilitation as a treatment modality for patients with pulmonary hypertension.

Timothy Fernandes, MD, MPH, is a board-certified pulmonologist who focuses on pulmonary vascular disease. He has a special interest in caring for patients who have venous thromboembolism, pulmonary arterial hypertension, and chronic thromboembolic pulmonary hypertension. Dr. Fernandes is active in clinical research investigating the progression of acute pulmonary embolism to chronic thromboembolic disease (CTEPH), and patient outcomes following pulmonary endarterectomy (PTE) surgery. He has been awarded the CHEST Foundation Clinical Research Grant in Pulmonary Arterial Hypertension, and the Thrombosis and Hemostasis Summit of North America Travel Award. Dr. Fernandes completed his fellowship training at UC San Diego School of Medicine and his residency at Case Western Reserve University School of Medicine, where he served as chief medical resident. He earned his medical degree at University of Cincinnati College of Medicine. Dr. Fernandes is board-certified in critical care medicine, pulmonary disease and internal medicine and is a fellow of the College of Chest Physicians."